vaccine

Dr. Anthony Fauci expressed "cautious optimism" Friday about the initial results from a coronavirus vaccine trial — which were widely celebrated this week — and said it remains "conceivable" that a vaccine for the deadly pathogen could be available by the end of the year.

Johnson & Johnson will stop selling talcum-based baby powder in the United States and Canada after being ordered to pay out billions of dollars related to lost legal battles over claims the product causes cancer.

The company made the announcement Tuesday. It denied allegations that the powder is responsible for health problems.

A vaccine manufacturer is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be eliciting in test subjects the kind of immune response capable of preventing disease.

Moderna, Inc., of Cambridge, Mass., developed the vaccine in collaboration with the National Institute of Allergy and Infectious Diseases. The results reported Monday come from an initial analysis of a Phase I study primarily designed to see if the vaccine is safe.

The World Health Organization's annual oversight convention will be held by teleconference beginning Monday, as the worst pandemic in modern history continues around the globe.

Most health experts agree that the need for a vaccine to prevent COVID-19 is clear.

"To return to a semblance of previous normality, the development of SARS-CoV-2 vaccines is an absolute necessity" is how a perspective in Science magazine puts it.

There's a chance that hundreds of millions of doses of a potential COVID-19 vaccine could be available by early next year, Dr. Anthony Fauci, a key member of the White House coronavirus task force, said Thursday, even though the federal government has not approved a vaccine against the virus.

Two of the world's largest vaccine manufacturers are joining forces to develop a new vaccine to prevent COVID-19.

Usually, the pharmaceutical behemoths GlaxoSmithKline and Sanofi are competitors, but in a conference call with reporters, GSK CEO Emma Walmsley said the coronavirus pandemic represented "an unprecedented global health threat," and, therefore, required new ways of doing business.